Brief: Talis Biomedical Posts Quarterly Loss Per Share Of $2.51
10/08/2021 22:47
Aug 10 (Reuters) - Talis Biomedical Corp TLIS.O :
* Q2 REVENUE $100,000
* Q2 REVENUE ESTIMATE $0 -- REFINITIV IBES DATA
* QTRLY LOSS PER SHARE $2.51
Source text for Eikon: ID:nGNX3HBLyy
Further company coverage: TLIS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Talis Biomedical
See all newsBrief: Talis Biomedical Says Nasdaq Believes Co Is 'Public Shell' And Continued Listing Of Its Common Stock Is No Longer Warranted
Brief: Talis Biomedical Says Accepting Voluntary Resignation Of Heinrich Dreismann From Board Effective August 1
Brief: Talis Biomedical Eliminates Andrew Lukowiak As President And Chief Scientific Officer
Talis Biomedical up on plans to explore strategic options, job cuts
Brief: Talis Biomedical Announces Exploration Of Strategic Alternatives And Cost Reduction Plan To Preserve Cash